Shenzhen YHLO Biotech Co., Ltd. (688575.SS)
CNY 16.47
(0.37%)
CNY 16.47
(0.37%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 825.74 Million CNY | -11.06% |
| 2022 | 874.83 Million CNY | 109.51% |
| 2021 | 417.56 Million CNY | 29.07% |
| 2020 | 323.52 Million CNY | 10.94% |
| 2019 | 291.61 Million CNY | 29.77% |
| 2018 | 224.7 Million CNY | 26.76% |
| 2017 | 177.26 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 163.77 Million CNY | -22.05% |
| 2024 Q1 | 210.09 Million CNY | -19.4% |
| 2024 Q3 | 225.52 Million CNY | 50.52% |
| 2023 Q2 | 189.36 Million CNY | -0.15% |
| 2023 FY | 778.06 Million CNY | -11.06% |
| 2023 Q3 | 222.59 Million CNY | 17.55% |
| 2023 Q1 | 189.64 Million CNY | 46.93% |
| 2023 Q4 | 260.65 Million CNY | 17.1% |
| 2022 Q2 | 297.01 Million CNY | 7.74% |
| 2022 FY | 874.83 Million CNY | 109.51% |
| 2022 Q4 | 129.07 Million CNY | -25.42% |
| 2022 Q1 | 275.68 Million CNY | 126.17% |
| 2022 Q3 | 173.06 Million CNY | -41.73% |
| 2021 Q1 | 82.6 Million CNY | -27.84% |
| 2021 FY | 417.56 Million CNY | 29.07% |
| 2021 Q4 | 121.89 Million CNY | 14.07% |
| 2021 Q2 | 106.21 Million CNY | 28.57% |
| 2021 Q3 | 106.85 Million CNY | 0.6% |
| 2020 Q2 | 70.3 Million CNY | 16.32% |
| 2020 Q4 | 114.47 Million CNY | 46.18% |
| 2020 FY | 323.52 Million CNY | 10.94% |
| 2020 Q3 | 78.31 Million CNY | 11.39% |
| 2020 Q1 | 60.43 Million CNY | 0.0% |
| 2019 FY | 291.61 Million CNY | 29.77% |
| 2018 FY | 224.7 Million CNY | 26.76% |
| 2017 FY | 177.26 Million CNY | 0.0% |